{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:54:57Z","timestamp":1791042897847,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1585,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1593\/neo.91460","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T12:59:00Z","timestamp":1429793940000},"page":"87-94","source":"Crossref","is-referenced-by-count":71,"title":["Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Jeanine M.","family":"Roodhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies H.","family":"Langenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost S.","family":"Vermaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn P.","family":"Lolkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Baars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els O.","family":"Witteveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile E.","family":"Voest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.91460_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","article-title":"Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?","volume":"2","author":"Rafii","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.91460_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1593\/neo.91460_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.1150224","article-title":"Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis","volume":"319","author":"Gao","year":"2008","journal-title":"Science"},{"key":"10.1593\/neo.91460_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1593\/neo.91460_bib5","first-page":"2870","article-title":"Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice","volume":"7","author":"Davidoff","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.91460_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"10.1593\/neo.91460_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI0214327","article-title":"Origin of endothelial progenitors in human postnatal bone marrow","volume":"109","author":"Reyes","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1593\/neo.91460_bib8","doi-asserted-by":"crossref","first-page":"18111","DOI":"10.1073\/pnas.0507158102","article-title":"Chemokines direct endothelial progenitors into tumor neovessels","volume":"102","author":"Spring","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.91460_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nm1200","article-title":"Contribution of bone marrow-derived endothelial cells to human tumor vasculature","volume":"11","author":"Peters","year":"2005","journal-title":"Nat Med"},{"key":"10.1593\/neo.91460_bib10","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2005-08-3210","article-title":"Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors","volume":"107","author":"Duda","year":"2006","journal-title":"Blood"},{"key":"10.1593\/neo.91460_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1535-6108(03)00240-X","article-title":"Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors","volume":"4","author":"Ruzinova","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.91460_bib12","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-06-2594","article-title":"Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma","volume":"13","author":"Yu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.91460_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1593\/neo.91460_bib14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1127592","article-title":"Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors","volume":"313","author":"Shaked","year":"2006","journal-title":"Science"},{"key":"10.1593\/neo.91460_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2008.08.001","article-title":"Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents","volume":"14","author":"Shaked","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.91460_bib16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/annonc\/mdm367","article-title":"Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells","volume":"18","author":"Farace","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1593\/neo.91460_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdh017","article-title":"Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients","volume":"15","author":"Beerepoot","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1593\/neo.91460_bib18","first-page":"4342","article-title":"Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells","volume":"63","author":"Bertolini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.91460_bib19","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1158\/1078-0432.CCR-04-2271","article-title":"Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity","volume":"1","author":"Beaudry","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.91460_bib20","first-page":"101","article-title":"Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis","volume":"7","author":"Shaked","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.91460_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.bjc.6602952","article-title":"Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer","volume":"94","author":"Furstenberger","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.91460_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1593\/neo.09490","article-title":"Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage\/dysfunction\/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index","volume":"11","author":"Goon","year":"2009","journal-title":"Neoplasia"},{"key":"10.1593\/neo.91460_bib23","first-page":"4341","article-title":"Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma","volume":"61","author":"Monestiroli","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.91460_bib24","first-page":"8345","article-title":"Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells","volume":"63","author":"Schuch","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.91460_bib25","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood-2004-06-2101","article-title":"Circulating endothelial progenitor cells in multiple myeloma: implications and significance","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"10.1593\/neo.91460_bib26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2005-04-1422","article-title":"Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity","volume":"106","author":"Shaked","year":"2005","journal-title":"Blood"},{"key":"10.1593\/neo.91460_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat Med"},{"key":"10.1593\/neo.91460_bib28","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1200\/JCO.2005.02.5635","article-title":"Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients","volume":"23","author":"Willett","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.91460_bib29","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V97.11.3658","article-title":"Resting and activated endothelial cells are increased in the peripheral blood of cancer patients","volume":"97","author":"Mancuso","year":"2001","journal-title":"Blood"},{"key":"10.1593\/neo.91460_bib30","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.97.26.14608","article-title":"Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood","volume":"97","author":"Chang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.91460_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nprot.2007.111","article-title":"A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood","volume":"2","author":"Duda","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1593\/neo.91460_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood-2005-11-4570","article-title":"Circulating endothelial cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy","volume":"108","author":"Mancuso","year":"2006","journal-title":"Blood"},{"key":"10.1593\/neo.91460_bib33","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1158\/0008-5472.CAN-05-4654","article-title":"Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer","volume":"66","author":"Dome","year":"2006","journal-title":"Cancer Res"},{"key":"10.1593\/neo.91460_bib34","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1200\/JCO.2008.17.4789","article-title":"Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer","volume":"26","author":"Dellapasqua","year":"2008","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1593\/neo.91460_bib35","article-title":"A phase I study of combretastatin A4 phosphate (CA4P) and bevacizumab in subjects with advanced solid tumors","volume":"26","author":"Nathan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.91460_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1\u03b1 induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.91460_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1096\/fj.05-5137fje","article-title":"VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization","volume":"20","author":"Li","year":"2006","journal-title":"FASEB J"},{"key":"10.1593\/neo.91460_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","article-title":"VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells","volume":"124","author":"Grunewald","year":"2006","journal-title":"Cell"},{"key":"10.1593\/neo.91460_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni813","article-title":"G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4","volume":"3","author":"Petit","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1593\/neo.91460_bib40","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1634\/stemcells.2006-0333","article-title":"Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection","volume":"24","author":"Lemoli","year":"2006","journal-title":"Stem Cells"},{"key":"10.1593\/neo.91460_bib41","first-page":"831","article-title":"Low-dose oral metronomic chemotherapy prevents mobilization of endothelial progenitor cells into the blood of cancer patients","volume":"22","author":"Stoelting","year":"2008","journal-title":"In Vivo"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558610800880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558610800880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:50:49Z","timestamp":1537689049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558610800880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1476558610800880"],"URL":"https:\/\/doi.org\/10.1593\/neo.91460","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}